Specialty Compounding Pharmacy Company | Pharma Tech Outlook Magazine
Pharma Tech Outlook

Pharma Tech Outlook: Specials Magazine

In the ever-evolving world of healthcare, Strive Compounding Pharmacy is redefining the role pharmacies can play in people’s personal health journeys. Founded with a bold vision to prioritize patients’ unique needs over cookie-cutter solutions and to create memorable patient experiences, Strive is a mission-driven pharmacy committed to quality, service, innovation, and challenging the status quo. As a 503A compounding pharmacy, it not only aligns with but also enables the broader movement of people taking ownership of their wellness. Strive achieves this by offering a wide variety of pharmaceutical products, including but not limited to hormone therapy, weight loss, longevity, sexual health, skincare, and more. Strive was born from a realization: people aren’t one-size-fits-all—so why should medicine be? One of Strive’s co-founders learned about compounding during pharmacy school and gravitated toward the more personalized model. The other co-founder, a pharmaceutical sales rep, grew tired of selling a drug that treated the side effects of another drug. Their passion for doing things differently complemented each other’s strengths and illuminated a path to make a meaningful difference in healthcare. And that’s exactly what they’ve done. In just seven years, Strive has grown from one location in Gilbert, Arizona, to eight pharmacy locations and licensure in all 50 states—an incredible feat for any pharmacy—becoming one of the largest compounding pharmacies in the nation. Interestingly, “growth” was never Strive’s primary goal, as it typically is for many businesses. The goal was to do something different, do it well, and do it consistently. The value Strive delivers to both healthcare providers and their patients has generated significant brand awareness, resulting in rapid growth. While other compounding pharmacies have plateaued, Strive has continuously found ways to scale while exemplifying compliance, quality, transparency, and service. Aligned by Purpose, Driven by Service “One of the primary contributors to our success is the dedication to speed of service without compromising quality,” says Matthew Montes de Oca, Chief Clinical Officer. “Unlike many traditional compounding pharmacies, which can take a week or more to deliver medications, we’ve optimized our processes to ship most compounded prescriptions within one to two business days.” This commitment to fast, reliable service is not merely a convenience—it’s a necessity in a healthcare landscape where patients cannot afford to wait. Zach Shurtleff, Vice President of Marketing, emphasizes that Strive’s value proposition extends far beyond speed: “Speed is critical, but it’s just the beginning,” he explains. “We’re also committed to transparency, personalized service, and high-quality products. We want our partners—physicians, clinics, veterinarians, and other healthcare providers—to feel supported every step of the way.” Strive’s broad reach, paired with a personalized, high-touch service model, allows it to serve as both a national provider and a locally responsive partner. Education also plays a central role in Strive’s mission. Recognizing that many healthcare providers may not be fully aware of the options and benefits of compounding, Strive has built a robust infrastructure to provide clinical support and education. Its team regularly engages with physicians to help them understand how compounded medications can enhance personalized care. “We view education as a two-way street,” says Montes de Oca. “We’re constantly learning from our partners—what’s working, what’s needed, and what can be improved. At the same time, we share our expertise to help them make informed decisions about treatment options. It’s a collaborative relationship.”

Contract Research Organization

Small and micro pharmaceutical companies are stepping up with exciting projects, creating a transformative wave in healthcare and the life sciences industry. To make a difference in alleviating patient suffering through innovative therapeutics and effectively managing their research workload, they must partner with resourceful contract research organizations (CROs). Yet, not all proficient CROs offer the responsiveness or affordability necessary for these smaller firms. Ki Health Partners, a leading CRO, caters specifically to the requirements of small pharma and biotech firms, ensuring they feel listened to and supported every step of the way. Having transitioned from private practice research sites, academic institutions and pharmaceutical companies, its team collectively offers a wealth of experience and expertise, crucial in effectively identifying and resolving client pain points. Believing that the ‘ki’ (key) to success is focusing on the client, Ki Health oversees every aspect of a clinical study from inception to completion. It also functions as a site management organization (SMO) maintaining its large pool of clinical trial sites. “We are responsive to the testing requirements of smaller pharma companies, offering them a personalized, hands-on experience tailored to their needs,” says Peter McAllister, co-founder and medical director of Ki Health Partners. Working hand-in-hand with clients, Ki Health ensures the success of the trials of their therapeutic products by providing best-in-class services in a timely, ethical and cost-effective manner. Each client is assigned a clinical research associate (CRA) and is free to personally reach out to the CEO or CMO via email or telephone. Its senior leadership is directly involved in day-to-day management and client interactions. The company’s small size and compact structure allow for a range of relationships devoid of unnecessary bureaucratic layers while keeping its team’s expertise intact.

Veeva Soultions Provider

At Deerfield Agency, the success of each life-sciences brand is deeply intertwined with the agency’s foundational commitment to client-centricity, which has rightfully earned it the title ‘Agency of Brand.’ Centered on the simple motto ‘How can we achieve more with less?’ the full-service agency delivers, from strategy through execution, to elevate brands to new heights. During the pandemic, this philosophy was put to the test as Deerfield navigated uncharted waters, spearheading a wave of innovation to meet new challenges head-on. Agile and problem-solvers at the core, the Deerfield team reassessed the traditional norms of direct engagement and deliberated a significant shift toward a digital-first approach. Embracing an omnichannel strategy and developing sophisticated sales tools, it helped clients quantify interactions, target diverse customer bases through personalized messages, and stand out in a sea of generic communications. “We are always invested in partnering with our clients and solving challenges together, creating something meaningful that not only addresses their immediate needs but fosters future commercial success,” says Juan Vasquez, CTO. Whether for emerging startups striving to establish their brand, small pharmaceutical firms preparing for commercialization, or even major industry players, Deerfield becomes an extension of its client’s team to devise a tailored marketing approach to meet distinct challenges and goals. One crucial challenge Deerfield addresses is the integration complexities of Veeva systems. Omnichannel strategies are pivotal, yet executing them effectively poses its own set of challenges. Veeva plays a crucial role here, especially when it comes to data management and the need for customized solutions that align with specific marketing strategies. Clients frequently encounter issues with disparate systems, such as varying CRM systems used by sales and marketing teams. Deerfield resolves these issues by streamlining these systems into a unified platform, providing a comprehensive view of the customer. This integration enables clients to consolidate data into data warehouses and equips them with insightful dashboards, enhancing their decision-making capabilities.

IN FOCUS

Elevating Compounding Pharmacy Standards Through Clinical Expertise and Digital Innovation

Specialty compounding pharmacies are enhancing patient care through digital compliance and partnerships with CROs, ensuring data integrity and operational excellence in personalized medicine.

Learn more

Specialty Compounding Pharmacies as Pillars of Scalable Personalized Healthcare

Specialty compounding pharmacies are evolving healthcare with personalized medicine, addressing unique patient needs, aging populations, and chronic disease management.

Learn more

EDITORIAL

The Integrated Future of Personalized Medicine

Patients no longer wait for one-size-fits-all treatments. Today’s healthcare demands precision, speed and seamless coordination from lab to bedside. The fusion of advanced formulation science, agile clinical development and intelligent digital infrastructure is changing what’s possible in medicine. This new era of pharma tech thrives on customization, compliance and connectivity, turning complex therapeutic challenges into targeted solutions that are safer, smarter and delivered with unprecedented efficiency.

This transformation is powered by three essential pillars. First, specialty compounding pharmacies that are developing personalized medications for patients with unique needs. The second pillar is made up of contract research organizations, which provide the scientific and operational backbone for efficient, compliant clinical trials. Lastly, Veeva solutions providers deliver the digital infrastructure that unifies regulatory, quality and commercial processes. Together, these components enable a more responsive, integrated and patient-focused pharmaceutical ecosystem, ensuring that innovation moves swiftly from concept to care.

In the November 2025 edition of Pharma Tech Outlook, we spotlight the innovations driving personalized medicine, efficient drug development and digital compliance in clinical research expertise.

The cover features Strive Compounding Pharmacy, a mission-driven pharmacy reimagining personalized medicine. It empowers patients and practitioners alike to move beyond one-size-fits-all medicine with its tailored therapies.

This edition also highlights visionary leaders reshaping their industries through science and sustainability. Lone Baekgaard, VP of animal and plant biosolutions R&D at Novonesis champions biology-driven solutions that enhance agriculture and animal health while reducing environmental impact. Shola Oyewole, VP of digital innovation at United Therapeutics Corporation, demonstrates how digital innovation, from artificial intelligence to regenerative medicine, is accelerating breakthroughs in drug development and organ transplantation.

We hope this edition sparks fresh perspectives on the future of pharma tech, where personalized care, scientific collaboration and digital innovation converge to transform patient outcomes.